Iodide

Iodide

SCHEMBL3862124

CCc1ccc(C)[n+](C)c1.[I-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.39
TP53 P04637 2/20 0.39
TAAR1 Q96RJ0 1/20 0.38
CYP2A6 P11509 1/20 0.37
LPL P06858 1/20 0.37
LIPG Q9Y5X9 1/20 0.37
ALDH1A1 P00352 1/20 0.35
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PLAU P00749 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
ALOX5 P09917 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
PLK1 P53350 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL641620 0.98 TP53 (0.40) CA2TP53TAAR1CYP2A6LPL
Hydrochloric Acid SCHEMBL11592858 0.95 CA2 (0.39) CA2TP53TAAR1CYP2A6LPL
SCHEMBL11770347 0.86 CA2 (0.46) CA2TP53ALDH1A1L3MBTL1SMN1; SMN2
SCHEMBL11770358 0.86 CA2 (0.41) CA2TP53LPLLIPGALDH1A1
Iodide SCHEMBL4336770 0.76 SMN1; SMN2 (0.39) CA2TP53TAAR1CYP2A6LPL
Iodide SCHEMBL3317180 0.76 CA2 (0.42) CA2TP53TAAR1CYP2A6LPL
SCHEMBL19458162 0.74 TP53 (0.40) CA2TP53TAAR1CYP2A6LPL
SCHEMBL641259 0.73 CA2 (0.39) CA2TP53TAAR1CYP2A6LPL
SCHEMBL1842853 0.73 CA2 (0.43) CA2TP53TAAR1CYP2A6LPL
SCHEMBL6089163 0.73 L3MBTL1 (0.50) CA2TP53TAAR1CYP2A6LPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9718754-B2 Methyl-iodide-free carbonylation of an alcohol to its homologous aldehyde and/or alcohol EASTMAN CHEMICAL COMPANY (US) 2017-08-01 US disclosed
US-9714206-B2 Methyl-iodide-free carbonylation of an alcohol to its homologous aldehyde and/or alcohol EASTMAN CHEMICAL COMPANY (US) 2017-07-25 US disclosed
US-20160251292-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL EASTMAN CHEMICAL COMPANY (US) 2016-09-01 US disclosed
US-20160185701-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL EASTMAN CHEMICAL COMPANY (US) 2016-06-30 US disclosed
US-20160185700-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL EASTMAN CHEMICAL COMPANY (US) 2016-06-30 US disclosed
US-9365479-B1 Methyl-iodide-free carbonylation of an alcohol to its homologous aldehyde and/or alcohol EASTMAN CHEMICAL COMPANY (US) 2016-06-14 US disclosed
US-9266807-B1 Conversion of alcohols to longer chain aldehydes or alcohols EASTMAN CHEMICAL COMPANY (US) 2016-02-23 US disclosed
US-9238606-B1 Methyl-Iodide-free carbonylation of methanol to acetaldehyde EASTMAN CHEMICAL COMPANY (US) 2016-01-19 US disclosed
WO-2009123675-A1 IMPROVED CARBONYLATION PROCESS EASTMAN CHEMICAL COMPANY (US) 2009-10-08 WO disclosed
US-20090247783-A1 CARBONYLATION PROCESS EASTMAN CHEMICAL COMPANY (US) 2009-10-01 US disclosed
US-7582792-B2 Carbonylation process EASTMAN CHEMICAL COMPANY (US) 2009-09-01 US disclosed
US-20070293695-A1 CARBONYLATION PROCESS EASTMAN CHEMICAL COMPANY (US) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185701-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL ADH1C, ADH5, ADH1A CA2 1377/4885TP53 2430/4885TAAR1 213/4885
US-20070293695-A1 CARBONYLATION PROCESS CBR3, HAO2, CA4 CA2 26/4885TP53 4441/4885TAAR1 1618/4885
US-20160251292-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL ADH1C, ADH5, ADH1A CA2 1558/4885TP53 2956/4885TAAR1 401/4885
US-20160185700-A1 METHYL-IODIDE-FREE CARBONYLATION OF AN ALCOHOL TO ITS HOMOLOGOUS ALDEHYDE AND/OR ALCOHOL ADH1C, ADH5, ADH1A CA2 1558/4885TP53 2956/4885TAAR1 401/4885
US-20090247783-A1 CARBONYLATION PROCESS CA4, HAO2, CA9 CA2 4/4885TP53 3769/4885TAAR1 1413/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.